Full Text Journal Articles by
Author Florian Roghmann

Advertisement

Find full text journal articles






Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy.

Karl H Tully, Hendrik Jütte, Ralph M Wirtz, Jonas Jarczyk, Ademi Santiago-Walker, Friedemann Zengerling, Johannes Breyer, Danijel Sikic, Maximilian C Kriegmair, Jost von Hardenberg, Bernd Wullich, Helge Taubert, Veronika Weyerer, Robert Stoehr, Christian Bolenz, Maximilian Burger, Stefan Porubsky, Arndt Hartmann, Florian Roghmann, Philipp Erben, Markus Eckstein,

<h4>Objective</h4>To examine the disease-specific survival(DSS) after checkpoint inhibitor(CPI) therapy based on FGFR alterations and FGFR mRNA expression levels in patients with metastatic urothelial cancer(mUCa) within a multi-center cohort.<h4>Methods</h4>Within a cohort of 72 patients with mUCa from five academic centers in Germany FGFR alterations, as well as FGFR1-4 mRNA expression levels ... Read more >>

Urology (Urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors: A Population-based Study Using SEER-Medicare Data.

Karl H Tully, Eugene B Cone, Alexander P Cole, Maxine Sun, Xi Chen, Maya Marchese, Florian Roghmann, Kerry L Kilbridge, Quoc-Dien Trinh,

<h4>Objective</h4>The objective of this study was to examine the risk of immune-related adverse events (irAEs) in patients with a preexisting autoimmune disease (pAID) presenting with a cutaneous melanoma receiving an immune checkpoint inhibitor (ICI) therapy.<h4>Methods</h4>Data from the Surveillance, Epidemiology, and End Results cancer registries and linked Medicare claims between January ... Read more >>

Am J Clin Oncol (American journal of clinical oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.

Hendrik Jütte, Moritz Reike, Ralph M Wirtz, Maximilian Kriegmair, Philipp Erben, Karl Tully, Veronika Weyerer, Markus Eckstein, Arndt Hartmann, Sebastian Eidt, Felix Wezel, Christian Bolenz, Andrea Tannapfel, Joachim Noldus, Florian Roghmann,

Patients with muscle-invasive bladder cancer (MIBC) that underwent neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) show improved overall survival, especially those with pathological complete response (pCR). The response to NAC according to molecular subtypes has been discussed. Molecular targets such as estrogen receptor (ESR1) and human epidermal growth factor ... Read more >>

J Pers Med (Journal of personalized medicine)
[2021, 11(6):]

Cited: 0 times

View full text PDF listing >>



Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra-operative frozen section.

Karl H Tully, Max Schulmeyer, Julian Hanske, Moritz J Reike, Marko Brock, Rudolf Moritz, Hendrik Jütte, Andrea Tannapfel, Christian von Bodman, Joachim Noldus, Rein-Jüri Palisaar, Florian Roghmann,

<h4>Objective</h4>To identify patients at risk for biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP) with intra-operative whole-mount frozen section (FS) of the prostate.<h4>Material and methods</h4>We examined differences in BCR between patients with initial negative surgical margins at FS, patients with final negative surgical margins with initial positive ... Read more >>

BJU Int (BJU international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Probability of Prostate Cancer Diagnosis following Negative Systematic and Targeted MRI: Transrectal Ultrasound Fusion Biopsy: A Real-Life Observational Study.

Nicolas von Landenberg, Julian Hanske, Joachim Noldus, Florian Roghmann, Karl H Tully, Jan Wald, Sebastian Berg, Marko Brock,

<h4>Introduction</h4>The risk of occult prostate carcinoma (PCa) after negative multiparametric MRI (mpMRI)-transrectal fusion biopsy (F-Bx) is unknown. To determine the false-negative predictive value, we examined PCa detection after prior negative F-Bx.<h4>Methods</h4>Between December 2012 and November 2016, 491 patients with suspected PCa and suspicious mpMRI findings underwent transrectal F-Bx. Patients with ... Read more >>

Urol Int (Urologia internationalis)
[2021, 105(5-6):446-452]

Cited: 0 times

View full text PDF listing >>



Changing the Prostate Cancer Detection Paradigm: Clinical Application of European Association of Urology Guideline-recommended Magnetic Resonance Imaging-based Risk Stratification in Men with Suspected Prostate Cancer.

Karl H Tully, Henning Bahlburg, Sebastian Berg, Julian Hanske, Nicolas von Landenberg, Joachim Noldus, Rein-Jüri Palisaar, Florian Roghmann, Marko Brock,

<h4>Background</h4>Multiparametric magnetic resonance imaging using the Prostate Imaging Reporting and Data System version 2.1 allows for a personalized, risk-stratified approach to indicating prostate biopsies (PBx) in order to reduce PBx and concomitant complications in men with suspected prostate cancer (PCa). One way to achieve this goal is to implement the ... Read more >>

Eur Urol Focus (European urology focus)
[2020, :]

Cited: 0 times

View full text PDF listing >>



In-Vitro Identification and In-Vivo Confirmation of DNA Methylation Biomarkers for Urothelial Cancer.

Christina U Köhler, Michael Walter, Kerstin Lang, Sabine Plöttner, Florian Roghmann, Joachim Noldus, Andrea Tannapfel, Yu Chun Tam, Heiko U Käfferlein, Thomas Brüning,

We identified DNA methylation targets specific for urothelial cancer (UC) by genome-wide methylation difference analysis of human urothelial (RT4, J82, 5637), prostate (LNCAP, DU-145, PC3) and renal (RCC-KP, CAKI-2, CAL-54) cancer cell lines with their respective primary epithelial cells. A large overlap of differentially methylated targets between all organs was ... Read more >>

Biomedicines (Biomedicines)
[2020, 8(8):]

Cited: 1 time

View full text PDF listing >>



Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size.

Karl H Tully, Marco Moschini, Friedrich-Carl E von Rundstedt, Atiqullah Aziz, Luis A Kluth, Andrea Necchi, Michael Rink, Kees Hendricksen, Paul Sargos, Malte W Vetterlein, Roland Seiler, Cedric Poyet, Wojciech Krajewski, Harun Fajkovic, Shahrokh F Shariat, Evanguelos Xylinas, Florian Roghmann,

<h4>Purpose</h4>To examine survival rates and to calculate the risk of disease recurrence, progression, overall, and cancer-specific mortality in patients diagnosed with high-risk NMIBC using a multi-institutional dataset to evaluate differences between the guidelines of the European Association of Urology and the guidelines of the National Comprehensive Cancer Network (NCCN) with ... Read more >>

Urol Oncol (Urologic oncology)
[2020, 38(11):851.e19-851.e25]

Cited: 0 times

View full text PDF listing >>



The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group.

Philipp Gild, Malte W Vetterlein, Roland Seiler, Andrea Necchi, Kees Hendricksen, Laura S Mertens, Florian Roghmann, Nicolas V Landenberg, Paolo Gontero, Marcus Cumberbatch, Jakub Dobruch, Thomas Seisen, Pietro Grande, David D'Andrea, Julien Anract, Evi Comploj, Armin Pycha, Karim Saba, Cedric Poyet, Bas W van Rhijn, Aidan P Noon, Morgan Roupret, Shahrokh F Shariat, Margit Fisch, Evanguelos Xylinas, Michael Rink,

<h4>Objective</h4>To prospectively study the impact of smoking on pathological response to neoadjuvant chemotherapy (NAC) in patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB).<h4>Materials & methods</h4>We collected standard clinicopathological variables, including smoking status (never, former, current) in patients undergoing NAC and RC for UCB at 12 European ... Read more >>

Surg Oncol (Surgical oncology)
[2020, 34:312-317]

Cited: 1 time

View full text PDF listing >>



Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].

J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H Maxim Bruins, Theo M De Reijke, Maria De Santis, Silke Gillessen, Nicholas James, Steven Maclennan, Juan Palou, Tom Powles, Maria J Ribal, Shahrokh F Shariat, Theo Van Der Kwast, Evanguelos Xylinas, Neeraj Agarwal, Tom Arends, Aristotle Bamias, Alison Birtle, Peter C Black, Bernard H Bochner, Michel Bolla, Joost L Boormans, Alberto Bossi, Alberto Briganti, Iris Brummelhuis, Max Burger, Daniel Castellano, Richard Cathomas, Arturo Chiti, Ananya Choudhury, Eva Compérat, Simon Crabb, Stephane Culine, Berardino De Bari, Willem De Blok, Pieter J L De Visschere, Karel Decaestecker, Konstantinos Dimitropoulos, Jose L Dominguez-Escrig, Stefano Fanti, Valerie Fonteyne, Mark Frydenberg, Jurgen J Futterer, Georgios Gakis, Bogdan Geavlete, Paolo Gontero, Bernhard Grubmüller, Shaista Hafeez, Donna E Hansel, Arndt Hartmann, Dickon Hayne, Ann M Henry, Virginia Hernandez, Harry Herr, Ken Herrmann, Peter Hoskin, Jorge Huguet, Barbara A Jereczek-Fossa, Rob Jones, Ashish M Kamat, Vincent Khoo, Anne E Kiltie, Susanne Krege, Sylvain Ladoire, Pedro C Lara, Annemarie Leliveld, Estefania Linares-Espinós, Vibeke Løgager, Anja Lorch, Yohann Loriot, Richard Meijer, M Carmen Mir, Marco Moschini, Hugh Mostafid, Arndt-Christian Müller, Christoph R Müller, James N'Dow, Andrea Necchi, Yann Neuzillet, Jorg R Oddens, Jan Oldenburg, Susanne Osanto, Wim J G Oyen, Luís Pacheco-Figueiredo, Helle Pappot, Manish I Patel, Bradley R Pieters, Karin Plass, Mesut Remzi, Margitta Retz, Jonathan Richenberg, Michael Rink, Florian Roghmann, Jonathan E Rosenberg, Morgan Rouprêt, Olivier Rouvière, Carl Salembier, Antti Salminen, Paul Sargos, Shomik Sengupta, Amir Sherif, Robert J Smeenk, Anita Smits, Arnulf Stenzl, George N Thalmann, Bertrand Tombal, Baris Turkbey, Susanne Vahr Lauridsen, Riccardo Valdagni, Antoine G Van Der Heijden, Hein Van Poppel, Mihai D Vartolomei, Erik Veskimäe, Antoni Vilaseca, Franklin A Vives Rivera, Thomas Wiegel, Peter Wiklund, Peter-Paul M Willemse, Andrew Williams, Richard Zigeuner, Alan Horwich,

Eur Urol (European urology)
[2020, 78(1):e48-e50]

Cited: 0 times

View full text PDF listing >>



Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.

Karl H Tully, Florian Roghmann, Joachim Noldus, Xi Chen, Lorine Häuser, Adam S Kibel, Guru P Sonpavde, Matthew Mossanen, Quoc-Dien Trinh,

<h4>Introduction</h4>The objective of this study was to examine the overall survival (OS) in patients diagnosed with high-grade T1 non-muscle-invasive bladder cancer treated with early radical cystectomy versus local treatment of the primary tumor, defined as endoscopic management with or without intravesical chemotherapy or immunotherapy.<h4>Patients and methods</h4>We identified 4900 patients with ... Read more >>

Clin Genitourin Cancer (Clinical genitourinary cancer)
[2020, 18(6):e651-e659]

Cited: 0 times

View full text PDF listing >>



The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.

Luca Afferi, Stefania Zamboni, R Jeffrey Karnes, Florian Roghmann, Paul Sargos, Francesco Montorsi, Alberto Briganti, Andrea Gallina, Agostino Mattei, Gerald Bastian Schulz, Kees Hendricksen, Charlotte S Voskuilen, Michael Rink, Cedric Poyet, Ottavio De Cobelli, Ettore di Trapani, Claudio Simeone, Matteo Soligo, Giuseppe Simone, Gabriele Tuderti, Mario Alvarez-Maestro, Luis Martínez-Piñeiro, Atiqullah Aziz, Shahrokh F Shariat, Mohammad Abufaraj, Evanguelos Xylinas, Marco Moschini, ,

<h4>Purpose</h4>To assess the impact of perioperative chemotherapy on survival in cN+ BCa patients and analyze it according to the pN status.<h4>Methods</h4>A retrospective analysis was conducted on 639 BCa patients with cTanyN1-3M0 BCa treated with radical cystectomy (RC) and bilateral lymph node dissection (LND) with or without perioperative chemotherapy in ten tertiary referral ... Read more >>

World J Urol (World journal of urology)
[2021, 39(2):443-451]

Cited: 0 times

View full text PDF listing >>



Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.

Natalya Benderska-Söder, Jan Hovanec, Beate Pesch, Peter J Goebell, Florian Roghmann, Joachim Noldus, Juri Rabinovich, Katharina Wichert, Jan Gleichenhagen, Heiko U Käfferlein, Christina U Köhler, Georg Johnen, Karoline Kernig, Oliver Hakenberg, Daniela Jahn, Tilman Todenhöfer, Arnulf Stenzl, Jochen Gleissner, Klaus Gerwert, Samir El-Mashtoly, Thomas Behrens, Thomas Brüning, Bernd J Schmitz-Dräger,

<h4>Background</h4>Follow-up recommendations for patients with nonmuscle invasive bladder cancer (NMIBC) are largely based upon expert opinion. A growing body of evidence suggests that current follow-up strategies for bladder cancer patients with low and intermediate risk represent overdiagnosis and may lead to overtreatment. The goal of this study is to explore ... Read more >>

Urol Oncol (Urologic oncology)
[2020, 38(12):886-895]

Cited: 1 time

View full text PDF listing >>



EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H Maxim Bruins, Theo M De Reijke, Maria De Santis, Silke Gillessen, Nicholas James, Steven Maclennan, Juan Palou, Tom Powles, Maria J Ribal, Shahrokh F Shariat, Theo Van Der Kwast, Evanguelos Xylinas, Neeraj Agarwal, Tom Arends, Aristotle Bamias, Alison Birtle, Peter C Black, Bernard H Bochner, Michel Bolla, Joost L Boormans, Alberto Bossi, Alberto Briganti, Iris Brummelhuis, Max Burger, Daniel Castellano, Richard Cathomas, Arturo Chiti, Ananya Choudhury, Eva Compérat, Simon Crabb, Stephane Culine, Berardino De Bari, Willem De Blok, Pieter J L De Visschere, Karel Decaestecker, Konstantinos Dimitropoulos, Jose L Dominguez-Escrig, Stefano Fanti, Valerie Fonteyne, Mark Frydenberg, Jurgen J Futterer, Georgios Gakis, Bogdan Geavlete, Paolo Gontero, Bernhard Grubmüller, Shaista Hafeez, Donna E Hansel, Arndt Hartmann, Dickon Hayne, Ann M Henry, Virginia Hernandez, Harry Herr, Ken Herrmann, Peter Hoskin, Jorge Huguet, Barbara A Jereczek-Fossa, Rob Jones, Ashish M Kamat, Vincent Khoo, Anne E Kiltie, Susanne Krege, Sylvain Ladoire, Pedro C Lara, Annemarie Leliveld, Estefania Linares-Espinós, Vibeke Løgager, Anja Lorch, Yohann Loriot, Richard Meijer, M Carmen Mir, Marco Moschini, Hugh Mostafid, Arndt-Christian Müller, Christoph R Müller, James N'Dow, Andrea Necchi, Yann Neuzillet, Jorg R Oddens, Jan Oldenburg, Susanne Osanto, Wim J G Oyen, Luís Pacheco-Figueiredo, Helle Pappot, Manish I Patel, Bradley R Pieters, Karin Plass, Mesut Remzi, Margitta Retz, Jonathan Richenberg, Michael Rink, Florian Roghmann, Jonathan E Rosenberg, Morgan Rouprêt, Olivier Rouvière, Carl Salembier, Antti Salminen, Paul Sargos, Shomik Sengupta, Amir Sherif, Robert J Smeenk, Anita Smits, Arnulf Stenzl, George N Thalmann, Bertrand Tombal, Baris Turkbey, Susanne Vahr Lauridsen, Riccardo Valdagni, Antoine G Van Der Heijden, Hein Van Poppel, Mihai D Vartolomei, Erik Veskimäe, Antoni Vilaseca, Franklin A Vives Rivera, Thomas Wiegel, Peter Wiklund, Andrew Williams, Richard Zigeuner, Alan Horwich,

<h4>Background</h4>Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial.<h4>Objective</h4>To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management.<h4>Design</h4>A steering committee compiled proposed statements regarding advanced and variant ... Read more >>

Eur Urol (European urology)
[2020, 77(2):223-250]

Cited: 21 times

View full text PDF listing >>



Reply by Authors.

Lisa Dahlkamp, Lorine Haeuser, Guido Winnekendonk, Christian von Bodman, Ulrich H Frey, Robin Epplen, Rein-Jueri Palisaar, Peter Bach, Joachim Noldus, Marko Brock, Florian Roghmann,

J Urol (The Journal of urology)
[2019, 202(5):897-898]

Cited: 0 times

View full text PDF listing >>



The value of nephrometry scoring systems in prediction of conversion to radical nephrectomy in patients scheduled for nephron-sparing surgery.

Lorine Haeuser, Lisa Dahlkamp, Joachim Noldus, Florian Roghmann,

Ann Transl Med (Annals of translational medicine)
[2019, 7(22):704]

Cited: 0 times

View full text PDF listing >>



Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer.

Nora Tabea Sibert, Sebastian Dieng, Alisa Oesterle, Günter Feick, Günther Carl, Thomas Steiner, Jörg Minner, Florian Roghmann, Björn Kaftan, Friedemann Zengerling, Andreas Hinkel, Burkhard Beyer, Axel Heidenreich, Nina Harke, Bernhard Brehmer, Jesco Pfitzenmaier, Jan Fichtner, Andreas Neisius, Peter Hammerer, Simone Wesselmann, Christoph Kowalski,

<h4>Purpose</h4>For patients with prostate cancer, validated and reliable instruments are essential for measuring patient-reported outcomes. The aim of this study was to validate the German version of the widely established Expanded Prostate Cancer Index Composite with 26 items (EPIC-26).<h4>Methods</h4>A German translation of the original questionnaire was tested in 3094 patients ... Read more >>

World J Urol (World journal of urology)
[2021, 39(1):11-25]

Cited: 4 times

View full text PDF listing >>



Interdisciplinary Comparison of PADUA and R.E.N.A.L. Scoring Systems for Prediction of Conversion to Nephrectomy in Patients with Renal Mass Scheduled for Nephron Sparing Surgery.

Lisa Dahlkamp, Lorine Haeuser, Guido Winnekendonk, Christian von Bodman, Ulrich H Frey, Robin Epplen, Rein-Jueri Palisaar, Peter Bach, Joachim Noldus, Marko Brock, Florian Roghmann,

<h4>Purpose</h4>We examined interdisciplinary variability using 2 established preoperative nephrometry scores to predict conversion to nephrectomy in patients with a renal mass who were scheduled for partial nephrectomy.<h4>Materials and methods</h4>A total of 229 consecutive candidates for partial nephrectomy were included in this study at a single institution between January 2013 and ... Read more >>

J Urol (The Journal of urology)
[2019, 202(5):890-898]

Cited: 3 times

View full text PDF listing >>



TGFBI Protein Is Increased in the Urine of Patients with High-Grade Urothelial Carcinomas, and Promotes Cell Proliferation and Migration.

Kerstin Lang, Selcan Kahveci, Nadine Bonberg, Katharina Wichert, Thomas Behrens, Jan Hovanec, Florian Roghmann, Joachim Noldus, Yu Chun Tam, Andrea Tannapfel, Heiko U Käfferlein, Thomas Brüning,

Here, we discovered TGFBI as a new urinary biomarker for muscle invasive and high-grade urothelial carcinoma (UC). After biomarker identification using antibody arrays, results were verified in urine samples from a study population consisting of 303 patients with UC, and 128 urological and 58 population controls. The analyses of possible ... Read more >>

Int J Mol Sci (International journal of molecular sciences)
[2019, 20(18):]

Cited: 1 time

View full text PDF listing >>



Salvage lymph node dissection in hormone-naïve men: How effective is surgery?

Julian Hanske, Jessica Ostholt, Florian Roghmann, Guido Müller, Katharina Braun, Benedikt Gomez, Nicolas von Landenberg, Christian von Bodman, Rein-Jüri Palisaar, Dieter Liermann, Joachim Noldus, Marko Brock,

<h4>Objective</h4>Salvage lymph node dissection (SLND) is still a questionable treatment approach for patients with nodal recurrence of prostate cancer after radical prostatectomy. We assessed the oncological benefit after SLND in hormone-naïve patients as well as the diagnostic accuracy of preoperative prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET/CT) scanning.<h4>Material ... Read more >>

Urol Oncol (Urologic oncology)
[2019, 37(11):812.e17-812.e24]

Cited: 2 times

View full text PDF listing >>



Editorial: early PSA-testing after radical prostatectomy-the truth behind the scenes.

Julian Hanske, Florian Roghmann, Joachim Noldus, Marko Brock,

Transl Androl Urol (Translational andrology and urology)
[2019, 8(Suppl 3):S307-S309]

Cited: 0 times

View full text PDF listing >>



Parastomal Hernia Repair With 3-D Mesh Implants After Radical Cystectomy and Ileal Conduit Urinary Diversion - A Single-center Experience Using a Purpose Made Alloplastic Mesh Implant.

Karl H Tully, Florian Roghmann, Jobst Pastor, Joachim Noldus, Christian von Bodman,

<h4>Objective</h4>To report and evaluate our open surgical technique for the treatment of parastomal hernias (PSH) after ileal conduit urinary diversion and results using a specifically designed, three-dimensional intraperitoneal onlay mesh aiming to minimize PSH recurrence and perioperative complications.<h4>Methods</h4>We retrospectively evaluated all patients who developed a PSH after ileal conduit urinary ... Read more >>

Urology (Urology)
[2019, 131:245-249]

Cited: 1 time

View full text PDF listing >>



Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.

Kathrin E Witzke, Frederik Großerueschkamp, Hendrik Jütte, Melanie Horn, Florian Roghmann, Nicolas von Landenberg, Thilo Bracht, Angela Kallenbach-Thieltges, Heiko Käfferlein, Thomas Brüning, Karin Schork, Martin Eisenacher, Katrin Marcus, Joachim Noldus, Andrea Tannapfel, Barbara Sitek, Klaus Gerwert,

Histopathological differentiation between severe urocystitis with reactive urothelial atypia and carcinoma in situ (CIS) can be difficult, particularly after a treatment that deliberately induces an inflammatory reaction, such as intravesical instillation of Bacillus Calmette-Guèrin. However, precise grading in bladder cancer is critical for therapeutic decision making and thus requires reliable ... Read more >>

Am J Pathol (The American journal of pathology)
[2019, 189(3):619-631]

Cited: 12 times

View full text PDF listing >>



The need to improve TURB: a diagnostic and therapeutic fundamental first step in the disease's management.

Marco Moschini, Florian Roghmann, Evanguelos Xylinas,

Transl Androl Urol (Translational andrology and urology)
[2019, 8(1):2-4]

Cited: 1 time

View full text PDF listing >>



Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.

Charlotte S Voskuilen, Roland Seiler, Michael Rink, Cédric Poyet, Aidan P Noon, Florian Roghmann, Andrea Necchi, Atiqullah Aziz, Alexandre Lavollé, Matthew J Young, Phillip Marks, Karim Saba, Bas W G van Rhijn, Elisabeth E Fransen van de Putte, Jason Ablat, Peter C Black, Roman Sosnowski, Jakub Dobruch, Pardeep Kumar, Samer Jallad, James W F Catto, Evanguelos Xylinas, Kees Hendricksen, ,

<h4>Background</h4>Urothelial carcinoma arising in a bladder diverticulum (UCBD) is uncommon, and data on treatment and outcome are sparse.<h4>Objective</h4>To analyze clinicopathological characteristics of UCBD and to compare outcome after radical cystectomy (RC) and partial cystectomy (PC).<h4>Design, setting, and participants</h4>Data of 115 UCBD patients treated with RC (n=81) or PC (n=34) between ... Read more >>

Eur Urol Focus (European urology focus)
[2020, 6(6):1226-1232]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
1.1676 s